Diagnosing acute HIV infection

Expert Review of Anti-Infective Therapy

Volumn 10, Issue 1, 2012, Pages 31-41

  Yerly, Sabine ^a,b   Hirschel, Bernard ^b  

^a Department of Genetic and Laboratory Medicine ^*  (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

acute HIV infection; diagnosis; primary infection; retroviral syndrome

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; RECOMBINANT ANTIGEN; VIRUS RNA;

ANTIBODY DETECTION; ANTIGEN DETECTION; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; LEARNING ALGORITHM; LIMIT OF DETECTION; NONHUMAN; NUCLEIC ACID AMPLIFICATION; POINT OF CARE TESTING; REVIEW; SCREENING TEST; SEROPREVALENCE; VIRUS DETECTION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE; WESTERN BLOTTING;

ACUTE DISEASE; AIDS SERODIAGNOSIS; ALGORITHMS; HIV; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES;

EID: 83455233864     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.11.154     Document Type: Review

References (103)

1. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus Type 1. Rakai project study group. N. Engl. J. Med. 342, 921-929 (2000).
2. Daar ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N. Engl. J. Med. 324, 961-964 (1991).
3. Pilcher CD, Joaki G, Hoffman IF, et al. Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS 21, 1723-1730 (2007).
4. Morrison CS, Demers K, Kwok C, et al. Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection. AIDS 24, 573-582 (2010).
5. Yerly S, Vora S, Rizzardi P, et al. Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS 15, 2287-2292 (2001).
6. Yerly S, Junier T, Gayet-Ageron A, et al. The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection. AIDS 23, 1415-1423 (2009).
7. Brenner BG, Roger M, Routy JP, et al. Quebec primary HIV infection study group. High rates of forward transmission events after acute/early HIV-1 infection. J. Infect. Dis. 195, 951-959 (2007).
8. Lewis F, Hughes GJ, Rambaut A, Pozniak A, Leigh Brown AJ. Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS Med 5, e50 (2008).
9. Cohen MS, Shaw GM, McMichael AJ, Haynes BF. Acute HIV-1 infection. N. Engl. J. Med. 364, 1943-1954 (2011).
10. Miller WC, Rosenberg NE, Rutstein SE, Powers KA. Role of acute and early HIV infection in the sexual transmission of HIV. Curr. Opin. HIV AIDS 5, 277-282 (2010).
11. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J. Infect. Dis. 191, 1403-1409 (2005).
12. Hollingsworth TD, Anderson RM, Fraser C. HIV-1 transmission, by stage of infection. J. Infect. Dis. 198, 687-693 (2008).
13. Powers KA, Ghani AC, Miller WC, et al. The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet 378, 256-268 (2011).
14. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N. Engl. J. Med. 365, 493-505 (2011).
15. Li Q, Skinner PJ, Ha SJ, et al. Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection. Science 323, 1726-1729 (2009).
16. Miller CJ, Li Q, Abel K, et al. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J. Virol. 79, 9217-9227 (2005).
17. Brenchley JM, Schacker TW, Ruff LE, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200, 749-759 (2004).
18. Veazey RS, DeMaria M, Chalifoux LV, et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280, 427-431 (1998).
19. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434, 1093-1097 (2005).
20. Schacker T, Little S, Connick E, et al. Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J. Infect. Dis. 183, 555-562 (2001).
21. Fiebig EW, Wright DJ, Rawal BD, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17, 1871-1879 (2003).
22. Tindall B, Barker S, Donovan B, et al. Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch. Intern. Med. 148, 945-949 (1988).
23. Ward JW, Bush TJ, Perkins HA, et al. The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N. Engl. J. Med. 321, 947-952 (1989).
24. Schacker T, Collier AC, Hughes J, Shea T, Corey L. Clinical and epidemiologic features of primary HIV infection. Ann. Intern. Med. 125, 257-264 (1996).
25. Lavreys L, Thompson ML, Martin HL Jr, et al. Primary human immunodeficiency virus type 1 infection: clinical manifestations among women in Mombasa, Kenya. Clin. Infect. Dis. 30, 486-490 (2000).
26. Hecht FM, Busch MP, Rawal B, et al. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 16, 1119-1129 (2002).
27. Daar ES, Little S, Pitt J, et al. Diagnosis of primary HIV-1 infection. Los Angeles county primary HIV infection recruitment network. Ann. Intern. Med. 134, 25-29 (2001).
28. Vanhems P, Hughes J, Collier AC, et al. Comparison of clinical features, CD4 and CD8 responses among patients with acute HIV-1 infection from Geneva, Seattle and Sydney. AIDS 14, 375-381 (2000).
29. Kinloch-De Los S, Hirschel B, Hoen B, et al. A controlled trial of zidovudine in primary human immunodeficiency virus infection. N. Engl. J. Med. 333, 408-413 (1995).
30. Chu C, Selwyn PA. Diagnosis and initial management of acute HIV infection. Am. Fam. Physician 81, 1239-1244 (2010).
31. Miller WC, Leone PA, McCoy S, Nguyen TQ, Williams DE, Pilcher CD. Targeted testing for acute HIV infection in North Carolina. AIDS 23, 835-843 (2009).
32. Powers KA, Miller WC, Pilcher CD, et al. Malawi UNC project acute HIV study team. Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm. AIDS 21, 2237-2242 (2007).
33. Tomaras GD, Yates NL, Liu P, et al. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J. Virol. 82, 12449-12463 (2008).
34. Fellay J, Shianna KV, Telenti A, Goldstein DB. Host genetics and HIV-1: the final phase? PLoS Pathog. 6, e1001033 (2010).
35. McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF. The immune response during acute HIV-1 infection: clues for vaccine development. Nat. Rev. Immunol. 10, 11-23 (2010).
36. Petersen LR, Satten GA, Dodd R, et al. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. Transfusion 34, 283-289 (1994).
37. Devare SG. Early diagnosis of HIV infection. J. Med. Virol. 79, S11-S15 (2007).
38. Gallarda JL, Henrard DR, Liu D, et al. Early detection of antibody to human immunodeficiency virus Type 1 by using an antigen conjugate immunoassay correlates with the presence of immunoglobulin M antibody. J. Clin. Microbiol. 30, 2379-2384 (1992).
39. Thorstensson R, Andersson S, Lindbäck S, et al. Evaluation of 14 commercial HIV-1/HIV-2 antibody assays using serum panels of different geographical origin and clinical stage including a unique seroconversion panel. J. Virol. Methods 70, 139-151 (1998).
40. Weber B, Orazi B, Raineri A, et al. Multicenter evaluation of a new 4th generation HIV screening assay Elecsys HIV combi. Clin. Lab 52, 463-473 (2006).
41. Weber B, Fall EH, Berger A, Doerr HW. Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays. J. Clin. Microbiol. 36, 2235-2239 (1998).
42. van Binsbergen J, Keur W, Siebelink A, et al. Strongly enhanced sensitivity of a direct anti-HIV-1/-2 assay in seroconversion by incorporation of HIV p24 Ag detection: a new generation Vironostika HIV Uni-Form II. J. Virol. Methods 76, 59-71 (1998).
43. Ly TD, Laperche S, Brennan C, et al. Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays. J. Virol. Methods 122, 185-194 (2004).
44. Eshleman SH, Khaki L, Laeyendecker O, et al. Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay. J. Acquir. Immu. Defic. Syndr. 52, 121-124 (2009).
45. Stekler JD, Swenson PD, Coombs RW, et al. HIV testing in a high-incidence population: is antibody testing alone good enough? Clin. Infect. Dis. 49, 444-453 (2009).
46. Patel P, Mackellar D, Simmons P, et al. Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch. Intern. Med. 170, 66-74 (2010).
47. Malm K, von Sydow M, Andersson S. Performance of three automated fourth-generation combined HIV antigen/antibody assays in large-scale screening of blood donors and clinical samples. Transfus. Med. 19, 78-88 (2009).
48. Sickinger E, Stieler M, Kaufman B, et al. Multicenter evaluation of a new, automated enzyme-linked immunoassay for detection of human immunodeficiency virus-specific antibodies and antigen. J. Clin. Microbiol. 42, 21-29 (2004).
49. Pandori MW, Hackett J Jr, Louie B, et al. Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting. J. Clin. Microbiol. 47, 2639-2642 (2009).
50. Bischof JJ, Kuruc JD, Embry JA, et al. Prospective Study of the ARCHITECTHIV Ag/Ab Combo 4th generation assay to detect HIV infection in STI clinics. AIDS 25(15), 1927-1929 (2011).
51. Gay C, Dibben O, Anderson JA, et al. Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy. PLoS One 6, e19617 (2011).
52. Pilcher CD, Fiscus SA, Nguyen TQ, et al. Detection of acute infections during HIV testing in North Carolina. N. Engl. J. Med. 352, 1873-1883 (2005).
53. Patel P, Klausner JD, Bacon OM, et al. Detection of acute HIV infections in high-risk patients in California. J. Acquir. Immu. Defic. Syndr. 42, 75-79 (2006).
54. Priddy FH, Pilcher CD, Moore RH, et al. Detection of acute HIV infections in an urban HIV counseling and testing population in the United States. J. Acquir. Immu. Defic. Syndr. 44, 196-202 (2007).
55. Fiscus SA, Pilcher CD, Miller WC, et al. Rapid, real-time detection of acute HIV infection in patients in Africa. J. Infect. Dis. 195, 416-424 (2007).
56. Stekler J, Swenson PD, Wood RW, Handsfield HH, Golden MR. Targeted screening for primary HIV infection through pooled HIV-RNA testing in men who have sex with men. AIDS 19, 1323-1325 (2005).
57. Gous N, Scott L, Perovic O, Venter F, Stevens W. Should South Africa be performing nucleic acid testing on HIV enzyme-linked immunosorbent assay-negative samples? J. Clin. Microbiol. 48, 3407-3409 (2010).
58. Patterson KB, Leone PA, Fiscus SA, et al. Frequent detection of acute HIV infection in pregnant women. AIDS 21, 2303-2308 (2007).
59. Morris SR, Little SJ, Cunningham T, Garfein RS, Richman DD, Smith DM. Evaluation of an HIV nucleic acid testing program with automated Internet and voicemail systems to deliver results. Ann. Intern. Med. 152, 778-785 (2010).
60. Truong HM, Grant RM, McFarland W, et al. Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance. AIDS 20, 2193-2197 (2006).
61. Temkin E, Marsiglia VC, Hague C, Erbelding E. Screening for acute human immunodeficiency virus infection in baltimore public testing sites. Sex Transm. Dis. 38, 374-377 (2011).
62. Greenwald JL, Burstein GR, Pincus J, Branson B. A rapid review of rapid HIV antibody tests. Curr. Infect. Dis. Rep. 8, 125-131 (2006).
63. Hutchinson AB, Branson BM, Kim A, Farnham PG. A meta-analysis of the effectiveness of alternative HIV counseling and testing methods to increase knowledge of HIV status. AIDS 20, 1597-1604 (2006).
64. Learmonth KM, McPhee DA, Jardine DK, et al. Assessing proficiency of interpretation of rapid human immunodeficiency virus assays in nonlaboratory settings: ensuring quality of testing. J. Clin. Microbiol. 46, 1692-1697 (2008).
65. Chiu YH, Ong J, Walker S, et al. Photographed rapid HIV test results pilot novel quality assessment and training schemes. PLoS One 6, e18294 (2011).
66. Pavie J, Rachline A, Loze B, et al. Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting. PLoS One 5, e11581 (2010).
67. Laforgerie E, Boucher B, Ly TD, et al. Sensitivity of 8 CE (European Community)-approved rapid disposable tests for anti-HIV antibody detection during and after seroconversion. J. Virol. Methods 165, 105-107 (2010).
68. Delaney KP, Branson BM, Uniyal A, et al. Evaluation of the performance characteristics of 6 rapid HIV antibody tests. Clin. Infect. Dis. 52, 257-263 (2011).
69. Black V, von Mollendorf CE, Moyes JA, Scott LE, Puren A, Stevens WS. Poor sensitivity of field rapid HIV testing: implications for mother-to-child transmission programme. BJOG 116, 1805-1808 (2009).
70. Klarkowski DB, Wazome JM, Lokuge KM, Shanks L, Mills CF, OBrien DP. The evaluation of a rapid in situ HIV confirmation test in a programme with a high failure rate of the WHO HIV two-test diagnostic algorithm. PLoS One 4, e4351 (2009).
71. Aghokeng AF, Mpoudi-Ngole E, Dimodi H, et al. Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon. PLoS One 4, e7702 (2009).
72. Walensky RP, Arbelaez C, Reichmann WM, et al. Revising expectations from rapid HIV tests in the emergency department. Ann. Intern. Med. 149, 153-160 (2008).
73. Gray RH, Makumbi F, Serwadda D, et al. Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study. BMJ 335, 188-191 (2007).
74. Beelaert G, Fransen K. Evaluation of a rapid and simple fourth-generation HIV screening assay for qualitative detection of HIV p24 antigen and/or antibodies to HIV-1 and HIV-2. J. Virol. Methods 168, 218-222 (2010).
75. Poljak M, Smit E, Ross J. 2008 European guideline on HIV testing. Int. J. STD AIDS. 20, 77-83 (2009).
76. Korn K, Weissbrich B, Henke-Gendo C, et al. Single-point mutations causing more than 100-fold underestimation of human immunodeficiency virus Type 1 (HIV-1) load with the Cobas TaqMan HIV-1 real-time PCR assay. J. Clin. Microbiol. 47, 1238-1240 (2009).
77. Colson P, Solas C, Moreau J, Motte A, Henry M, Tamalet C. Impaired quantification of plasma HIV-1 RNA with a commercialized real-time PCR assay in a couple of HIV-1-infected individuals. J. Clin. Virol. 39, 226-229 (2007).
78. Damond F, Roquebert B, Bénard A, et al. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays. J. Clin. Microbiol. 45, 3436-3438 (2007).
79. Holguín M, López M, Molinero V. Soriano, Performance of three commercial viral load assays, versant human immunodeficiency virus Type 1 (HIV-1) RNA bDNA v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1, and NucliSens HIV-1 EasyQ v1.2, testing HIV-1 non-B subtypes and recombinant variants. J. Clin. Microbiol. 46, 2918-2923 (2008).
80. Ross L, Lim ML, Liao Q, et al. Prevalence of antiretroviral drug resistance and resistance-associated mutations in antiretroviral therapy-naive HIV-infected individuals from 40 United States cities. HIV Clin. Trials 8, 1-8 (2007).
81. Huang HY, Daar ES, Sax PE, et al. The prevalence of transmitted antiretroviral drug resistance in treatment-naive patients and factors influencing first-line treatment regimen selection. HIV Med. 9, 285-293 (2008).
82. Wheeler WH, Ziebell RA, Zabina H, et al. Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006. AIDS 24, 1203-1212 (2010).
83. Vercauteren J, Wensing AM, van de Vijver DA, et al. Transmission of drug-resistant HIV-1 is stabilizing in Europe. J. Infect. Dis. 200, 1503-1508 (2009).
84. Rich JD, Merriman NA, Mylonakis E, et al. Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series. Ann. Intern. Med. 130, 37-39 (1999).
85. van Zyl GU, Korsman SN, Maree L, Preiser W. NucliSens EasyQ HIV-1 V1.2 system: detection of human plasma-derived background signal. J. Virol. Methods 165, 318-319 (2010).
86. Kakaiya R, Gordon S, Zimmerman A, Verlinsky R, Ahmed S, Phillips M. False-positive nucleic acid test results for human immunodeficiency virus RNA and hepatitis C virus RNA: an underappreciated problem. Transfusion 51, 225-226 (2011).
87. Coco A, Kleinhans E. Prevalence of primary HIV infection in symptomatic ambulatory patients. Ann. Fam. Med 3, 400-404 (2005).
88. Pincus JM, Crosby SS, Losina E, et al. Acute human immunodeficiency virus infection in patients presenting to an urban urgent care center. Clin. Infect. Dis 37, 1699-1704 (2003).
89. Rosenberg ES, Caliendo AM, Walker BD. Acute HIV infection among patients tested for mononucleosis. N. Engl. J. Med. 340, 969 (1999).
90. Bebell LM, Pilcher CD, Dorsey G, et al. Acute HIV-1 infection is highly prevalent in Ugandan adults with suspected malaria. AIDS 24, 1945-1952 (2010).
91. Hutchinson AB, Patel P, Sansom SL, et al. Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings. PLoS Med. 7, e1000342 (2010).
92. Juusola JL, Brandeau ML, Long EF, Owens DK, Bendavid E. The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the United States. AIDS 25, 1779-1787 (2011).
93. Pilcher CD, Christopoulos KA, Golden M. Public health rationale for rapid nucleic acid or p24 antigen tests for HIV. J. Infect. Dis. 201(Suppl. 1), S7-S15 (2010).
94. Tang W, Chow WH, Li Y, Kong H, Tang YW, Lemieux B. Nucleic acid assay system for tier II laboratories and moderately complex clinics to detect HIV in low-resource settings. J. Infect. Dis. 201(Suppl. 1), S46-S51 (2010).
95. Tang S, Hewlett I. Nanoparticle-based immunoassays for sensitive and early detection of HIV-1 capsid (p24) antigen. J. Infect. Dis. 201(Suppl. 1), S59-S64 (2010).
96. Lee HH, Dineva MA, Chua YL, Ritchie AV, Ushiro-Lumb I, Wisniewski CA. Simple amplification-based assay: a nucleic acid-based point-of care platform for HIV-1 testing. J. Infect. Dis. 201(Suppl. 1), S65-S72 (2010).
97. Wang S, Xu F, Demirci U. Advances in developing HIV-1 viral load assays for resource-limited settings. Biotechnol. Adv. 28, 770-781 (2010).
98. Centers for Disease Control and Prevention. HIV counseling and testing in publicly funded sites annual report 1997-1998. Atlanta, GA, USA: CDC (2001). www.cdc.gov/hiv/pubs/cts98.pdf (Accessed 26 October 2011)
99. Centers for Disease Control and Prevention, WHO, and office of the United States global AIDS coordinator. Guidelines for assuring the accuracy and reliability of HIV rapid testing: applying a quality system approach. Geneva, WHO (2005). www.who.int/diagnostics
100. Yeni-P. Rapport 2010: Prise en charge des personnes infectées par le VIH. www.sante.gouv.fr (Accessed 8 September 2011)
101. Guidelines and Recommendations. Bern, Swiss Federal Office of Public Health (2008). www.bag.admin.ch/hiv- aids/05464/05490/05494/index. html?lang=en (Accessed 8 September 2011)
102. UNAIDS/WHO working group on gloal HIV/AIDS/STI surveillance. Guidelines for using HIV testing technologies in surveillance: selection, evaluation and implementation. http://data.unaids.org/publications/IRC-pub02/jc602- hivsurvguidel-en.pdf (Accessed 25 October 2011)
103. Association of Public Health Laboratories. Conference calls focus on new trends in HIV diagnostics. www.aphl.org/AboutAPHL/publications/Documents/ID- 2011August- HIVIssueBrief.pdf (Accessed 25 October 2011)